Can a wearable glucose sensor be trusted in the ICU? new study aims to find out

NCT ID NCT07611721

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is checking how accurate the Dexcom G7 continuous glucose monitor is for patients in the intensive care unit after major abdominal surgery or organ transplant. Researchers will place two sensors on each patient—one that is calibrated and used to guide insulin dosing, and one that is not calibrated and kept hidden. By comparing the readings from both sensors to standard blood glucose measurements, they hope to determine whether the device can reliably detect dangerous highs and lows in blood sugar in critically ill patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dexcom G7 continuous glucose monitor (device)
What this could lead to
If successful, this could show that the Dexcom G7 is reliable enough for routine use in intensive care, potentially improving glucose management for critically ill patients.
What could go wrong
This is a small, early-stage accuracy study (62 participants) in a specific ICU setting, so results may not apply to all patients or general hospital wards. The device may still have errors in detecting very low or high blood sugar.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CGM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute of Clinical and Experimental Medice

    RECRUITING

    Prague, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.